Fostering Coopetition Through Market Extension and Co-Creation in the Global Pharmaceutical Sector

39 Pages Posted: 9 Jun 2011 Last revised: 15 Dec 2015

See all articles by Christos N. Pitelis

Christos N. Pitelis

Head of International Business Department

Andreas Panagopoulos

University of Crete - Department of Economics

Panos Desyllas

University of Bath School of Management

Date Written: December 1, 2015

Abstract

We explore conditions under which collaboration between pharmaceutical firms from 'advanced' and emerging countries becomes preferable to rivalry. We show that that when agreements, such as Trade Related Aspects of Intellectual Property (IP) Rights, allow advanced country firms to take legal action against emerging country firms, whose products are perceived as infringing their IP, collaboration can prove preferable to both parties when the latter can leverage complementary assets and capabilities to extend and co-create market space. This co-opetitive outcome is fostered when the scope and duration of IP rights is contestable. Important implications follow for managerial practice.

Keywords: patents, TRIPS, MNPCs, bargaining

JEL Classification: L0, K0, O24, O32, O33, O34

Suggested Citation

Pitelis, Christos N. and Panagopoulos, Andreas and Desyllas, Panos, Fostering Coopetition Through Market Extension and Co-Creation in the Global Pharmaceutical Sector (December 1, 2015). Available at SSRN: https://ssrn.com/abstract=1860004 or http://dx.doi.org/10.2139/ssrn.1860004

Christos N. Pitelis (Contact Author)

Head of International Business Department ( email )

Leeds, LS2 9JT
United Kingdom

Andreas Panagopoulos

University of Crete - Department of Economics ( email )

Rethymno, GR-74100
Greece

Panos Desyllas

University of Bath School of Management ( email )

Claverton Down
Bath, BA2 7AY
United Kingdom

HOME PAGE: http://www.desyllas.org

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
148
Abstract Views
1,329
Rank
356,750
PlumX Metrics